Novartis to Buy Gene Therapy Company AveXis for $8.7 Billion – Wall Street Journal
Wall Street Journal |
Novartis to Buy Gene Therapy Company AveXis for $8.7 Billion
Wall Street Journal Novartis to Buy Gene Therapy Company AveXis for $8.7 Billion. Novartis expects the deal to slightly hit core operating income in 2018 and 2019. Swiss drugmaker Novartis said the deal is expected to close in mid-2018. Photo: arnd wiegmann/Reuters. By … Novartis to Buy AveXis in $8.7 Billion Gene–Therapy Deal Novartis enters deal to acquire gene therapy company AveXis for $8.7 billion Novartis to buy AveXis in $8.7bn US gene–therapy deal |
